COX-2 Inhibitor

February 27, 2012

A class of anti-inflammatory drug that blocks Cox-2 enzyme activity without impeding the activity of Cox-1. Vioxx is the best-known drug in this class, due to Merck’s withdrawal of it from the marketplace, after a possible link to cardiac episodes was uncovered.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks